1-169541237-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000130.5(F5):​c.3853C>A​(p.Leu1285Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 1,603,754 control chromosomes in the GnomAD database, including 24,165 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 1350 hom., cov: 26)
Exomes 𝑓: 0.17 ( 22815 hom. )

Consequence

F5
NM_000130.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:9

Conservation

PhyloP100: -0.143

Publications

22 publications found
Variant links:
Genes affected
F5 (HGNC:3542): (coagulation factor V) This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance. [provided by RefSeq, Oct 2008]
F5 Gene-Disease associations (from GenCC):
  • thrombophilia due to activated protein C resistance
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • congenital factor V deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • East Texas bleeding disorder
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068129003).
BP6
Variant 1-169541237-G-T is Benign according to our data. Variant chr1-169541237-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.174 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F5NM_000130.5 linkc.3853C>A p.Leu1285Ile missense_variant Exon 13 of 25 ENST00000367797.9 NP_000121.2 P12259

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F5ENST00000367797.9 linkc.3853C>A p.Leu1285Ile missense_variant Exon 13 of 25 1 NM_000130.5 ENSP00000356771.3 P12259
F5ENST00000367796.3 linkc.3868C>A p.Leu1290Ile missense_variant Exon 13 of 25 5 ENSP00000356770.3 A0A0A0MRJ7

Frequencies

GnomAD3 genomes
AF:
0.162
AC:
23833
AN:
147284
Hom.:
1353
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.157
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.225
Gnomad EAS
AF:
0.0917
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.172
Gnomad NFE
AF:
0.165
Gnomad OTH
AF:
0.163
GnomAD2 exomes
AF:
0.174
AC:
43421
AN:
249792
AF XY:
0.177
show subpopulations
Gnomad AFR exome
AF:
0.169
Gnomad AMR exome
AF:
0.132
Gnomad ASJ exome
AF:
0.252
Gnomad EAS exome
AF:
0.0957
Gnomad FIN exome
AF:
0.204
Gnomad NFE exome
AF:
0.180
Gnomad OTH exome
AF:
0.172
GnomAD4 exome
AF:
0.174
AC:
253871
AN:
1456364
Hom.:
22815
Cov.:
129
AF XY:
0.175
AC XY:
127054
AN XY:
724344
show subpopulations
African (AFR)
AF:
0.173
AC:
5766
AN:
33290
American (AMR)
AF:
0.137
AC:
6054
AN:
44048
Ashkenazi Jewish (ASJ)
AF:
0.251
AC:
6534
AN:
25990
East Asian (EAS)
AF:
0.0892
AC:
3526
AN:
39548
South Asian (SAS)
AF:
0.199
AC:
16933
AN:
85180
European-Finnish (FIN)
AF:
0.204
AC:
10854
AN:
53170
Middle Eastern (MID)
AF:
0.158
AC:
910
AN:
5748
European-Non Finnish (NFE)
AF:
0.174
AC:
192715
AN:
1109260
Other (OTH)
AF:
0.176
AC:
10579
AN:
60130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
13787
27573
41360
55146
68933
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6764
13528
20292
27056
33820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.162
AC:
23841
AN:
147390
Hom.:
1350
Cov.:
26
AF XY:
0.162
AC XY:
11665
AN XY:
71960
show subpopulations
African (AFR)
AF:
0.157
AC:
6245
AN:
39850
American (AMR)
AF:
0.145
AC:
2158
AN:
14900
Ashkenazi Jewish (ASJ)
AF:
0.225
AC:
761
AN:
3380
East Asian (EAS)
AF:
0.0915
AC:
459
AN:
5018
South Asian (SAS)
AF:
0.184
AC:
843
AN:
4572
European-Finnish (FIN)
AF:
0.192
AC:
1923
AN:
10010
Middle Eastern (MID)
AF:
0.180
AC:
51
AN:
284
European-Non Finnish (NFE)
AF:
0.165
AC:
10959
AN:
66426
Other (OTH)
AF:
0.162
AC:
333
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
913
1826
2738
3651
4564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.179
Hom.:
2127
TwinsUK
AF:
0.183
AC:
677
ALSPAC
AF:
0.173
AC:
667
ESP6500AA
AF:
0.176
AC:
775
ESP6500EA
AF:
0.175
AC:
1502
ExAC
AF:
0.179
AC:
21699
Asia WGS
AF:
0.154
AC:
535
AN:
3462
EpiCase
AF:
0.183
EpiControl
AF:
0.183

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

multiple AR variants in same gene - keep for nowAllele frequency is common in at least one population database (frequency: 25.185% in gnomAD_ExomesFounderPop) based on the frequency threshold of 5.0% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease. -

Thrombophilia due to activated protein C resistance Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital factor V deficiency Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Budd-Chiari syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Factor V deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Thrombophilia due to thrombin defect Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.20
DANN
Benign
0.16
DEOGEN2
Benign
0.028
T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.099
N
LIST_S2
Benign
0.55
T;T
MetaRNN
Benign
0.0068
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
M;.
PhyloP100
-0.14
PrimateAI
Benign
0.17
T
PROVEAN
Benign
-0.29
N;N
REVEL
Benign
0.031
Sift
Benign
0.15
T;T
Sift4G
Benign
0.29
T;T
Polyphen
0.0030
B;.
Vest4
0.083
MPC
0.22
ClinPred
0.0053
T
GERP RS
-1.4
Varity_R
0.024
gMVP
0.19
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1046712; hg19: chr1-169510475; COSMIC: COSV63123971; API